Sales Growth YoY (Last Twelve Months): Organovo Corp (ONVO)

Graphic logo of Organovo Holdings, Inc. (ONVO)

Organovo Holdings, Inc. (ONVO) collaborates with laboratories to test drugs on bioprinted tissues, although the product technology upgrade stage is only beginning to build growth potential. The year-over-year sales growth rate for the TTM resolves this dissonance, with the current level standing at -85.90. Consequently, Organovo Holdings, Inc. (ONVO) is scaling the implementation of 3D models to study metabolic pathologies, aiming to capture the B2B segment of the pharmaceutical market.

Sales Growth YoY (Last Twelve Months): Organovo Holdings Inc (ONVO) for 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for Organovo Corp (ONVO)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Organovo Holdings Inc
Mass-produced product of Organovo Holdings Inc

For Organovo Holdings, Inc. (ONVO), a leader in 3D bioprinting, revenue growth rates over the last twelve months reflect the actual scaling speed of demand for NovoGen technology. By analyzing year-over-year sales dynamics using the TTM methodology, an investor assesses the percentage change in revenue relative to the previous year, which confirms the commercial demand for bioprinted tissues within the R&D sectors of pharma behemoths and determines the fundamental stability of the business.

Who Organovo Holdings, Inc. competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Agape ATP - Trailing Twelve Months Sales Growth|Revenue Growth YoY (Last 12 Months) PLUR (Pluri Inc)|Annual Revenue Growth (Last Twelve Months) Synlogic Inc.|Sales Growth YoY (Last Twelve Months) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Trailing Twelve Months Revenue Growth|Spruce Biosciences Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Sales Growth YoY (Last Twelve Months)|Lumos Pharma - Revenue Dynamics YoY (Last Twelve Months)|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)